MoneyWorks4Me

Kopran - Quaterly Results

25 May 2023 Evaluate
The Revenue for the quarter ended  March 2023 of Rs. 802.28 millions grew by 24.38 % from Rs. 645.03 millions.Profit saw a slight increase of 15.61%to Rs. 55.18  millions from Rs. 47.73 millions.Operating Profit saw a handsome growth to 94.37 millions from 89.61 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 802.28 645.03 24.38 2730.95 2045.20 33.53 2730.95 2045.20 33.53
Other Income 20.74 22.80 -9.04 160.86 80.27 100.40 160.86 80.27 100.40
PBIDT 94.37 89.61 5.31 439.99 234.40 87.71 439.99 234.40 87.71
Interest 8.41 7.97 5.52 26.72 29.53 -9.52 26.72 29.53 -9.52
PBDT 85.96 81.64 5.29 413.27 204.87 101.72 413.27 204.87 101.72
Depreciation 10.89 10.61 2.64 44.12 43.23 2.06 44.12 43.23 2.06
PBT 75.07 71.03 5.69 369.15 161.64 128.38 369.15 161.64 128.38
TAX 19.89 23.30 -14.64 56.63 44.20 28.12 56.63 44.20 28.12
Deferred Tax 0.22 1.67 -86.83 -2.09 6.73 -131.05 -2.09 6.73 -131.05
PAT 55.18 47.73 15.61 312.52 117.44 166.11 312.52 117.44 166.11
Equity 482.12 482.12 0.00 482.12 482.12 0.00 482.12 482.12 0.00
PBIDTM(%) 11.76 13.89 -15.33 16.11 11.46 40.57 16.11 11.46 40.57
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..